Seres therapeutics to present at canaccord genuity 43rd annual growth conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that seres management will present at the canaccord genuity 43rd annual growth conference on wednesday, august 9, 2023, at 3:00 p.m. et. an audio webcast of the presentation will be available under the “investors and news” section of seres' website. a replay of the presentation will become available approximately one hour after the event and will be archived for.
MCRB Ratings Summary
MCRB Quant Ranking